Literature DB >> 11511382

3alpha,5alpha-THP in the raphe magnus attenuates PTZ-induced myoclonic seizures.

C A Frye1, N A Muscatiello.   

Abstract

Whether progesterone (P(4)) and its metabolite, 5alpha-pregnan-3alpha-ol-20-one (3alpha,5alpha-THP) have anti-seizure effects through actions in the raphe magnus (NRM) was investigated. Ovariectomized, Long-Evans rats with unilateral implants into the NRM of P(4) or its metabolite, 5alpha-pregnan-3alpha-ol-20-one (3alpha,5alpha-THP) had a significantly lower incidence of myoclonic seizures and less EEG activity following pentylenetetrazol (PTZ; 70 mg/kg, IP) administration than did rats with control implants. Progestin implants that missed the NRM were not effective at reducing ictal activity. Following P(4) implants to the NRM levels of P(4), and following P(4) and 3alpha,5alpha-THP implants to the NRM, 3alpha,5alpha-THP levels in the ventral hindbrain were increased above those seen in rats with control implants. These data suggest that progestins' anti-seizure effects in the NRM may be involve actions of 3alpha,5alpha-THP.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11511382     DOI: 10.1016/s0006-8993(01)02560-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

1.  Progesterone attenuates depressive behavior of younger and older adult C57/BL6, wildtype, and progesterone receptor knockout mice.

Authors:  Cheryl A Frye
Journal:  Pharmacol Biochem Behav       Date:  2011-06-06       Impact factor: 3.533

Review 2.  The diverse role of the raphe 5-HTergic systems in epilepsy.

Authors:  He-Ming Cheng; Chen-Shu Gao; Qiu-Wen Lou; Zhong Chen; Yi Wang
Journal:  Acta Pharmacol Sin       Date:  2022-05-25       Impact factor: 6.150

3.  Syntaxin 1B Mediates Berberine's Roles in Epilepsy-Like Behavior in a Pentylenetetrazole-Induced Seizure Zebrafish Model.

Authors:  Yang-Min Zheng; Bo Chen; Jian-Dong Jiang; Jing-Pu Zhang
Journal:  Front Mol Neurosci       Date:  2018-11-26       Impact factor: 5.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.